Hello. It's Mark Kris from Memorial Sloan Kettering. Recently, I presented information about the published trials of neoadjuvant nivolumab chemotherapy vs chemotherapy, showing robust, disease-free ...

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update The working group recommends a preferred definition of pathologic complete response (pCR) as the absence ...